-
Atalanta sack coach Juric after poor start to season
-
Trump threatens $1 billion action as BBC apologises for speech edit
-
Gattuso wants 'maximum commitment' as Italy's World Cup bid on the line
-
Indian capital car blast kills at least eight
-
Deadly measles surge sees Canada lose eradicated status
-
Brazil's Lula urges 'defeat' of climate deniers as COP30 opens
-
Strangled by jihadist blockade, Malians flee their desert town
-
US Supreme Court declines to hear case challenging same-sex marriage
-
'Fired-up' Fritz sees off Musetti in ATP Finals
-
Injured Courtois set to miss Belgium World Cup qualifiers
-
Bulatov, pillar of Russian contemporary art scene, dies at 92
-
Fritz sees off Musetti in ATP Finals
-
US strikes on alleged drug boats kill six more people
-
Sarkozy released from jail 'nightmare' pending appeal trial
-
COP30 has a mascot: the fiery-haired guardian of Brazil's forest
-
The Sudanese who told the world what happened in El-Fasher
-
Three things we learned from the Sao Paulo Grand Prix
-
ASC acquire majority share in Atletico Madrid
-
Ferrari boss tells Hamilton, Leclerc to drive, not talk
-
Bank of England seeks to 'build trust' in stablecoins
-
China suspends 'special port fees' on US vessels for one year
-
French court frees ex-president Sarkozy from jail pending appeal
-
No link between paracetamol and autism, major review finds
-
Typhoon Fung-wong floods Philippine towns, leaves 5 dead in its wake
-
France's Sarkozy says prison a 'nightmare' as prosecutors seek his release
-
Guinness maker Diageo picks new CEO after US tariffs cloud
-
China suspends 'special port fees' on US vessels
-
US senators take major step toward ending record shutdown
-
Typhoon Fung-wong leaves flooded Philippine towns in its wake
-
From Club Med to Beverly Hills: Assinie, the Ivorian Riviera
-
The 'ordinary' Arnie? Glen Powell reboots 'The Running Man'
-
Typhoon exposes centuries-old shipwreck off Vietnam port
-
French court to decide if ex-president Sarkozy can leave jail
-
China lifts sanctions on US units of South Korea ship giant Hanwha
-
Japan death row inmate's sister still fighting, even after release
-
Taylor sparks Colts to Berlin win as Pats streak hits seven
-
Dreyer, Pellegrino lift San Diego to 4-0 MLS Cup playoff win over Portland
-
Indonesia names late dictator Suharto a national hero
-
Fourth New Zealand-West Indies T20 washed out
-
Tanzania Maasai fear VW 'greenwashing' carbon credit scheme
-
Chinese businesswoman faces jail after huge UK crypto seizure
-
Markets boosted by hopes for deal to end US shutdown
-
Amazon poised to host toughest climate talks in years
-
Ex-jihadist Syrian president due at White House for landmark talks
-
Saudi belly dancers break taboos behind closed doors
-
The AI revolution has a power problem
-
Big lips and botox: In Trump's world, fashion and makeup get political
-
NBA champion Thunder rally to down Grizzlies
-
US senators reach deal that could end record shutdown
-
Weakening Typhoon Fung-wong exits Philippines after displacing 1.4 million
A New Era in Patient Affordability: TailorMed Builds the Industry Infrastructure to Tackle Medication Costs at Scale
Facing Soaring Drug Prices, TailorMed's Affordability Network Bridges Care and Financial Relief
NEW YORK, NY / ACCESS Newswire / April 24, 2025 / Millions of Americans today face an impossible choice between affording life-saving medications and risking severe financial hardship. TailorMed is tackling this challenge by bringing healthcare providers, specialty pharmacies, life science companies, and patients together in one coordinated network - streamlining access to financial assistance so patients can stay on-therapy and achieve better outcomes.
On April 29, at 4:00 p.m. PT during Asembia AXS25, TailorMed CEO and co-founder Srulik Dvorsky will moderate "It Takes a Network: Tackling Affordability Together," joined by senior leaders from Pfizer, Walgreens Specialty Pharmacy, MetroHealth, and Pink Fund. This strategic roundtable will demonstrate how TailorMed's collaborative network turns these partnerships into real-world solutions that ease patient financial burdens and improve care.
"The soaring cost of medications is creating an untenable situation for patients, forcing too many to choose financial stability over essential treatments," said Dvorsky. "Our colleagues at Pfizer, Walgreens, Pink Fund, and MetroHealth share our passion and recognize the need to fundamentally change how affordability is managed, and ensure patients can access vital treatments without financial hardship. We are grateful that our partners will join this panel discussion to share their expertise."
TailorMed's extensive affordability network, the largest of its kind, ensures patients find the care pathways they need, when they need them. By bringing together healthcare providers, specialty pharmacies, life science companies, and nonprofit organizations, TailorMed leverages cutting-edge technology and collaborative partnerships to eliminate financial barriers, dramatically improving patient outcomes and easing systemic healthcare burdens.
TailorMed representatives will also be available throughout the summit at booth #2014 for discussions and demonstrations of their affordability solutions.
For additional information on TailorMed's innovative approaches to medication affordability, visit https://tailormed.co/.
About TailorMed
TailorMed is a comprehensive platform dedicated to removing financial barriers across the medication continuum - from affordability and access to adherence. TailorMed transforms healthcare collaboration among patients, providers, pharmacies, life sciences companies, and payers, ensuring every patient receives the treatments they need promptly. With the nation's largest Affordability Network deployed in more than 800 hospitals, 1,300 clinics, and 1,400 pharmacies, TailorMed enables stakeholders to deliver seamless patient experiences and drive better healthcare outcomes. Learn more at tailormed.co.
Media Contact:
Jennifer Martin, VP, Marketing
312.882.4402 | [email protected]
PR Contact:
Glenn Goldberg
Parallel Communications Group
+1 516 776-3282
LinkedIn
𝕏: @Parallel_PR
[email protected]
SOURCE: TailorMed
View the original press release on ACCESS Newswire
B.Finley--AMWN